UniProt ID | SIN3B_HUMAN | |
---|---|---|
UniProt AC | O75182 | |
Protein Name | Paired amphipathic helix protein Sin3b | |
Gene Name | SIN3B {ECO:0000312|HGNC:HGNC:19354} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1162 | |
Subcellular Localization | Nucleus . | |
Protein Description | Acts as a transcriptional repressor. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Interacts with MAD-MAX heterodimers by binding to MAD. The heterodimer then represses transcription by tethering SIN3B to DNA. Also forms a complex with FOXK1 which represses transcription. With FOXK1, regulates cell cycle progression probably by repressing cell cycle inhibitor genes expression.. | |
Protein Sequence | MAHAGGGSGGSGAGGPAGRGLSGARWGRSGSAGHEKLPVHVEDALTYLDQVKIRFGSDPATYNGFLEIMKEFKSQSIDTPGVIRRVSQLFHEHPDLIVGFNAFLPLGYRIDIPKNGKLNIQSPLTSQENSHNHGDGAEDFKQQVPYKEDKPQVPLESDSVEFNNAISYVNKIKTRFLDHPEIYRSFLEILHTYQKEQLNTRGRPFRGMSEEEVFTEVANLFRGQEDLLSEFGQFLPEAKRSLFTGNGPCEMHSVQKNEHDKTPEHSRKRSRPSLLRPVSAPAKKKMKLRGTKDLSIAAVGKYGTLQEFSFFDKVRRVLKSQEVYENFLRCIALFNQELVSGSELLQLVSPFLGKFPELFAQFKSFLGVKELSFAPPMSDRSGDGISREIDYASCKRIGSSYRALPKTYQQPKCSGRTAICKELDHWTLLQGSWTDDYCMSKFKNTCWIPGYSAGVLNDTWVSFPSWSEDSTFVSSKKTPYEEQLHRCEDERFELDVVLETNLATIRVLESVQKKLSRMAPEDQEKFRLDDSLGGTSEVIQRRAIYRIYGDKAPEIIESLKKNPVTAVPVVLKRLKAKEEEWREAQQGFNKIWREQYEKAYLKSLDHQAVNFKQNDTKALRSKSLLNEIESVYDEHQEQHSEGRSAPSSEPHLIFVYEDRQILEDAAALISYYVKRQPAIQKEDQGTIHQLLHQFVPSLFFSQQLDLGASEESADEDRDSPQGQTTDPSERKKPAPGPHSSPPEEKGAFGDAPATEQPPLPPPAPHKPLDDVYSLFFANNNWYFFLRLHQTLCSRLLKIYRQAQKQLLEYRTEKEREKLLCEGRREKGSDPAMELRLKQPSEVELEEYYPAFLDMVRSLLEGSIDPTQYEDTLREMFTIHAYVGFTMDKLVQNIARQLHHLVSDDVCLKVVELYLNEKKRGAAGGNLSSRCVRAARETSYQWKAERCMADENCFKVMFLQRKGQVIMTIELLDTEEAQTEDPVEVQHLARYVEQYVGTEGASSSPTEGFLLKPVFLQRNLKKFRRRWQSEQARALRGEARSSWKRLVGVESACDVDCRFKLSTHKMVFIVNSEDYMYRRGTLCRAKQVQPLVLLRHHQHFEEWHSRWLEDNVTVEAASLVQDWLMGEEDEDMVPCKTLCETVHVHGLPVTRYRVQYSRRPASP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MAHAGGGSGGSGAGG CCCCCCCCCCCCCCC | 43.16 | 29255136 | |
11 | Phosphorylation | AGGGSGGSGAGGPAG CCCCCCCCCCCCCCC | 29.06 | 29255136 | |
19 | Methylation | GAGGPAGRGLSGARW CCCCCCCCCCCCCCC | 45.01 | 58859561 | |
29 | Phosphorylation | SGARWGRSGSAGHEK CCCCCCCCCCCCCCC | 32.91 | 24719451 | |
31 | Phosphorylation | ARWGRSGSAGHEKLP CCCCCCCCCCCCCCC | 32.12 | 23312004 | |
36 | Ubiquitination | SGSAGHEKLPVHVED CCCCCCCCCCCCHHH | 53.03 | - | |
46 | Phosphorylation | VHVEDALTYLDQVKI CCHHHHHHHHHHHEE | 24.61 | 28509920 | |
47 | Phosphorylation | HVEDALTYLDQVKIR CHHHHHHHHHHHEEE | 14.77 | 28509920 | |
74 | Phosphorylation | EIMKEFKSQSIDTPG HHHHHHHHCCCCCHH | 34.19 | 21406692 | |
76 | Phosphorylation | MKEFKSQSIDTPGVI HHHHHHCCCCCHHHH | 29.53 | 24719451 | |
79 | Phosphorylation | FKSQSIDTPGVIRRV HHHCCCCCHHHHHHH | 21.92 | 24719451 | |
122 | Phosphorylation | NGKLNIQSPLTSQEN CCEECCCCCCCCCCC | 20.34 | 23401153 | |
125 | Phosphorylation | LNIQSPLTSQENSHN ECCCCCCCCCCCCCC | 31.57 | 23663014 | |
126 | Phosphorylation | NIQSPLTSQENSHNH CCCCCCCCCCCCCCC | 43.08 | 23663014 | |
130 | Phosphorylation | PLTSQENSHNHGDGA CCCCCCCCCCCCCCH | 25.55 | 23663014 | |
146 | Phosphorylation | DFKQQVPYKEDKPQV HHHHHCCCCCCCCCC | 28.31 | - | |
239 (in isoform 1) | Ubiquitination | - | 40.64 | 21906983 | |
239 | Ubiquitination | GQFLPEAKRSLFTGN HHHCHHHHHHHHCCC | 40.64 | 2190698 | |
239 (in isoform 3) | Ubiquitination | - | 40.64 | 21906983 | |
239 (in isoform 2) | Ubiquitination | - | 40.64 | 21906983 | |
241 | Phosphorylation | FLPEAKRSLFTGNGP HCHHHHHHHHCCCCC | 27.42 | - | |
253 | Phosphorylation | NGPCEMHSVQKNEHD CCCCEEECCCCCCCC | 25.57 | 28555341 | |
262 | Phosphorylation | QKNEHDKTPEHSRKR CCCCCCCCHHHHCCC | 39.71 | 30576142 | |
266 | Phosphorylation | HDKTPEHSRKRSRPS CCCCHHHHCCCCCCH | 37.52 | 28985074 | |
270 | Phosphorylation | PEHSRKRSRPSLLRP HHHHCCCCCCHHHCC | 52.13 | 23312004 | |
273 | Phosphorylation | SRKRSRPSLLRPVSA HCCCCCCHHHCCCCC | 38.64 | 25159151 | |
279 | Phosphorylation | PSLLRPVSAPAKKKM CHHHCCCCCCCHHHC | 31.08 | 25159151 | |
284 | Acetylation | PVSAPAKKKMKLRGT CCCCCCHHHCCCCCC | 61.27 | 7851831 | |
304 | Phosphorylation | AAVGKYGTLQEFSFF EEECCCCCCHHCCHH | 23.37 | - | |
381 | Phosphorylation | APPMSDRSGDGISRE CCCCCCCCCCCCCCC | 46.34 | 29083192 | |
386 | Phosphorylation | DRSGDGISREIDYAS CCCCCCCCCCCHHHH | 29.41 | 29083192 | |
393 | Phosphorylation | SREIDYASCKRIGSS CCCCHHHHHHCCCCC | 17.59 | 29083192 | |
406 | Ubiquitination | SSYRALPKTYQQPKC CCCCCCCCCCCCCCC | 61.79 | - | |
531 | Phosphorylation | EKFRLDDSLGGTSEV HHHCCCCCCCCCHHH | 28.69 | 23403867 | |
535 | Phosphorylation | LDDSLGGTSEVIQRR CCCCCCCCHHHHHHH | 21.66 | 23403867 | |
536 | Phosphorylation | DDSLGGTSEVIQRRA CCCCCCCHHHHHHHH | 32.89 | 23403867 | |
548 | Phosphorylation | RRAIYRIYGDKAPEI HHHHHHHHCCCHHHH | 15.41 | 29523821 | |
551 | Ubiquitination | IYRIYGDKAPEIIES HHHHHCCCHHHHHHH | 62.57 | - | |
558 | Phosphorylation | KAPEIIESLKKNPVT CHHHHHHHHHHCCCC | 34.77 | 29523821 | |
590 | Ubiquitination | EAQQGFNKIWREQYE HHHHHHHHHHHHHHH | 41.19 | - | |
600 | Phosphorylation | REQYEKAYLKSLDHQ HHHHHHHHHHHCCHH | 26.23 | 20068231 | |
602 | Ubiquitination | QYEKAYLKSLDHQAV HHHHHHHHHCCHHCC | 35.97 | - | |
603 | Phosphorylation | YEKAYLKSLDHQAVN HHHHHHHHCCHHCCC | 36.11 | 20068231 | |
616 | Phosphorylation | VNFKQNDTKALRSKS CCCCCCCHHHHHCHH | 26.26 | 20068231 | |
630 | Phosphorylation | SLLNEIESVYDEHQE HHHHHHHHHHHHHHH | 31.47 | 27732954 | |
632 | Phosphorylation | LNEIESVYDEHQEQH HHHHHHHHHHHHHHH | 25.54 | 27732954 | |
640 | Phosphorylation | DEHQEQHSEGRSAPS HHHHHHHCCCCCCCC | 41.25 | 27732954 | |
709 | Phosphorylation | QQLDLGASEESADED HCCCCCCCCCCCCCC | 39.85 | - | |
712 | Phosphorylation | DLGASEESADEDRDS CCCCCCCCCCCCCCC | 36.65 | - | |
719 | Phosphorylation | SADEDRDSPQGQTTD CCCCCCCCCCCCCCC | 21.73 | - | |
728 | Phosphorylation | QGQTTDPSERKKPAP CCCCCCHHHCCCCCC | 53.49 | - | |
739 | Phosphorylation | KPAPGPHSSPPEEKG CCCCCCCCCCHHHCC | 47.90 | 23401153 | |
740 | Phosphorylation | PAPGPHSSPPEEKGA CCCCCCCCCHHHCCC | 41.25 | 30266825 | |
817 | Ubiquitination | RTEKEREKLLCEGRR HCHHHHHHHHHHCCH | 53.64 | - | |
877 | Phosphorylation | DTLREMFTIHAYVGF HHHHHHHHHHHHHCC | 15.56 | - | |
881 | Phosphorylation | EMFTIHAYVGFTMDK HHHHHHHHHCCCHHH | 6.22 | - | |
990 | Phosphorylation | EVQHLARYVEQYVGT HHHHHHHHHHHHHCC | 11.61 | 25022875 | |
994 | Phosphorylation | LARYVEQYVGTEGAS HHHHHHHHHCCCCCC | 6.32 | 29978859 | |
997 | Phosphorylation | YVEQYVGTEGASSSP HHHHHHCCCCCCCCC | 22.62 | 25022875 | |
1001 | Phosphorylation | YVGTEGASSSPTEGF HHCCCCCCCCCCCCC | 42.05 | 19276368 | |
1002 | Phosphorylation | VGTEGASSSPTEGFL HCCCCCCCCCCCCCC | 39.54 | 25159151 | |
1003 | Phosphorylation | GTEGASSSPTEGFLL CCCCCCCCCCCCCCC | 33.09 | 25159151 | |
1005 | Phosphorylation | EGASSSPTEGFLLKP CCCCCCCCCCCCCCH | 51.17 | 25022875 | |
1071 | Phosphorylation | KMVFIVNSEDYMYRR CEEEEECCHHHCHHC | 22.43 | - | |
1074 | Phosphorylation | FIVNSEDYMYRRGTL EEECCHHHCHHCCCC | 7.62 | 29759185 | |
1076 | Phosphorylation | VNSEDYMYRRGTLCR ECCHHHCHHCCCCCC | 7.31 | 29759185 | |
1140 | Phosphorylation | PCKTLCETVHVHGLP CCHHHEEEEEECCEE | 18.21 | 26074081 | |
1149 | Phosphorylation | HVHGLPVTRYRVQYS EECCEECEEEEEEEC | 21.75 | 26074081 | |
1151 | Phosphorylation | HGLPVTRYRVQYSRR CCEECEEEEEEECCC | 13.03 | 26074081 | |
1155 | Phosphorylation | VTRYRVQYSRRPASP CEEEEEEECCCCCCC | 10.99 | 26074081 | |
1156 | Phosphorylation | TRYRVQYSRRPASP- EEEEEEECCCCCCC- | 12.53 | 26074081 | |
1161 | Phosphorylation | QYSRRPASP------ EECCCCCCC------ | 33.55 | 26074081 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SIN3B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SIN3B_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...